Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S S Joshi

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Toxicology and Applied Pharmacology|May 1, 1997
A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivoJ E Mata, S S Joshi, B Palen, et al.
Molecular and Cellular Biochemistry|August 17, 1999
The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cellsX Ye, R L Krohn, W Liu, et al.
Leukemia|October 1, 1988
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10)W P Vaughan, C I Civin, D D Weisenburger, et al.
International Journal of Oncology|September 15, 1998
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cellsS S Joshi, N N Babushkina-Patz, D J Verbik, et al.
Blood|February 15, 1992
Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture techniqueJ G Sharp, S S Joshi, J O Armitage, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Oncogene|June 10, 2014
Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophagesS Kumar, M P Torres, S Kaur, et al.
Bone Marrow Transplantation|March 5, 1998
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesZ S Pavletic, S S Joshi, S J Pirruccello, et al.
Cytotherapy|December 9, 2003
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind studyS S Joshi, M R Bishop, J C Lynch, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Toxicology and Applied Pharmacology|May 1, 1997
A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivoJ E Mata, S S Joshi, B Palen, et al.
Molecular and Cellular Biochemistry|August 17, 1999
The cytotoxic effects of a novel IH636 grape seed proanthocyanidin extract on cultured human cancer cellsX Ye, R L Krohn, W Liu, et al.
Leukemia|October 1, 1988
Acute leukemia expressing the normal human hematopoietic stem cell membrane glycoprotein CD34 (MY10)W P Vaughan, C I Civin, D D Weisenburger, et al.
International Journal of Oncology|September 15, 1998
Antitumor activity of human umbilical cord blood cells: A comparative analysis with peripheral blood and bone marrow cellsS S Joshi, N N Babushkina-Patz, D J Verbik, et al.
Blood|February 15, 1992
Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture techniqueJ G Sharp, S S Joshi, J O Armitage, et al.
Leukemia & Lymphoma|December 1, 1995
Effects of BCR-ABL antisense oligonucleotides (AS-ODN) on human chronic myeloid leukemic cells: AS-ODN as effective purging agentsA G Wu, S S Joshi, W C Chan, et al.
Leukemia & Lymphoma|November 9, 2001
Oligonucleotide enhanced cytotoxicity of Idarubicin for lymphoma cellsJ G Sharp, M R Bishop, B Copple, et al.
Oncogene|June 10, 2014
Smoking accelerates pancreatic cancer progression by promoting differentiation of MDSCs and inducing HB-EGF expression in macrophagesS Kumar, M P Torres, S Kaur, et al.
Bone Marrow Transplantation|March 5, 1998
Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignanciesZ S Pavletic, S S Joshi, S J Pirruccello, et al.
Cytotherapy|December 9, 2003
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind studyS S Joshi, M R Bishop, J C Lynch, et al.
Pageof 10